Nonviral skin gene therapy

被引:60
作者
Vogel, JC [1 ]
机构
[1] NCI, Dermatol Branch, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1089/104303400750035780
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Nonviral skin gene therapy is an effective method to directly deliver and transiently express genes in the skin. Several different nonviral delivery methods have been successfully used and are analyzed here for their efficiency and efficacy in achieving specific therapeutic applications. For one important and frequently used application of nonviral skin gene therapy, genetic immunization, the types of resulting immune responses (Th1 versus Th2) will depend on which delivery method is used. In addition, we discuss the contributions of DNA as an immunostimulatory adjuvant in genetic immunization and how activation of skin dendritic cells and induction of IL-12 expression are mechanistically important in this process. Nonviral skin gene therapy has also been successfully used to enhance tumor regression in animal models, frequently by inducing a specific immune response against the tumor. In the future, nonviral skin gene therapy may be successfully used for the treatment of additional skin diseases if genes can be selectively delivered and expressed in specific skin cells, and if increased level and duration of gene expression can be achieved.
引用
收藏
页码:2253 / 2259
页数:7
相关论文
共 57 条
[51]   A direct in vivo approach for skin gene therapy [J].
Vogel, JC .
PROCEEDINGS OF THE ASSOCIATION OF AMERICAN PHYSICIANS, 1999, 111 (03) :190-197
[52]   Genetic immunization with glycoprotein 63 cDNA results in a helper T cell type 1 immune response and protection in a murine model of leishmaniasis [J].
Walker, PS ;
Scharton-Kersten, T ;
Rowton, ED ;
Hengge, U ;
Bouloc, A ;
Udey, MC ;
Vogel, JC .
HUMAN GENE THERAPY, 1998, 9 (13) :1899-1907
[53]   Immunostimulatory oligodeoxynucleotides promote protective immunity and provide systemic therapy for leishmaniasis via IL-12-and IFN-γ-dependent mechanisms [J].
Walker, PS ;
Scharton-Kersten, T ;
Krieg, AM ;
Love-Homan, L ;
Rowton, ED ;
Udey, MC ;
Vogel, JC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (12) :6970-6975
[54]   Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization [J].
Weiner, GJ ;
Liu, HM ;
Wooldridge, JE ;
Dahle, CE ;
Krieg, AM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (20) :10833-10837
[55]   INTRODUCTION OF FOREIGN GENES INTO TISSUES OF LIVING MICE BY DNA-COATED MICROPROJECTILES [J].
WILLIAMS, RS ;
JOHNSTON, SA ;
RIEDY, M ;
DEVIT, MJ ;
MCELLIGOTT, SG ;
SANFORD, JC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (07) :2726-2730
[56]   Genetic vaccines - a revolution in vaccinology? [J].
Xiang, ZQ ;
Pasquini, S ;
He, Z ;
Deng, H ;
Wang, Y ;
BlaszczykThurin, MA ;
Ertl, HCJ .
SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 1997, 19 (02) :257-268
[57]   INVIVO AND INVITRO GENE-TRANSFER TO MAMMALIAN SOMATIC-CELLS BY PARTICLE BOMBARDMENT [J].
YANG, NS ;
BURKHOLDER, J ;
ROBERTS, B ;
MARTINELL, B ;
MCCABE, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (24) :9568-9572